Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Feasibility of Neonatal Screening for Spinal Amyotrophy”

2 trials

Showing 2 of 2 results

Not applicableStudy completedNCT05481164
What this trial is testing

Newborn Screening for Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
University of Oxford 33,568
Not applicableUnknownNCT05645250
What this trial is testing

Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine

Who this might be right for
Feasibility of Neonatal Screening for Spinal Amyotrophy
University Hospital, Strasbourg, France 220,000

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation